OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30082155

Shandong Dongyue Organosilicon Materials Co Ltd

Specialty ChemicalsVerified

Shandong Dongyue Organosilicon Materials Co Ltd has a liquidity position that is medium in risk, with a current ratio of 2.44, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquidity_fpt is not available, but the free cash flow of 314,382,960 CNY suggests the company is generating positive cash from operations after capital expenditures. The company's profitability is weak, with a net loss of 19,309,190 CNY and an operating loss of 26,802,740 CNY. Its return on equity is -0.39%, and return on assets is -0.33%, both significantly below the typical performance of the Specialty Chemicals industry. These metrics suggest the company is underperforming in terms of capital efficiency and operational returns. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk of revenue volatility due to regional economic shifts or supply chain disruptions. The absence of segment or geographic breakdown in the financial data limits the ability to assess exposure to specific markets or products. The company's growth trajectory is uncertain, with no disclosed revenue growth or decline in the most recent period. The operating cash flow of 215,187,890 CNY and free cash flow of 314,382,960 CNY suggest the company is generating positive cash, but the net loss indicates that this is not translating into profitability. The capital expenditure of -21,409,910 CNY is relatively small compared to the company's total assets, suggesting limited investment in growth. The company faces a medium liquidity risk, with a debt-to-equity ratio of 0.09 and a current ratio of 2.44. The risk assessment indicates that the company has negative net cash after subtracting total debt, which could limit its ability to fund operations or invest in growth without external financing. The dilution risk is low, with no significant changes in shares outstanding between basic and diluted shares. No recent events, such as filings or transcripts, are disclosed in the available data. The absence of recent disclosures limits the ability to assess the company's strategic direction or operational changes.

30-day price · 300821+0.93 (+6.9%)
Low$13.26High$16.29Close$14.32As of21 May, 00:00 UTC
Profile
CompanyShandong Dongyue Organosilicon Materials Co Ltd
Ticker300821.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Shandong Dongyue Organosilicon Materials Co Ltd produces and sells organosilicon materials, primarily used in the chemical industry for applications such as silicone resins, silicone oils, and silicone rubber.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Shandong Dongyue Organosilicon Materials Co Ltd has a liquidity position that is medium in risk, with a current ratio of 2.44, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquidity_fpt is not available, but the free cash flow of 314,382,960 CNY suggests the company is generating positive cash from operations after capital expenditures. The company's profitability is weak, with a net loss of 19,309,190 CNY and an operating loss of 26,802,740 CNY. Its return on equity is -0.39%, and return on assets is -0.33%, both significantly below the typical performance of the Specialty Chemicals industry. These metrics suggest the company is underperforming in terms of capital efficiency and operational returns. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk of revenue volatility due to regional economic shifts or supply chain disruptions. The absence of segment or geographic breakdown in the financial data limits the ability to assess exposure to specific markets or products. The company's growth trajectory is uncertain, with no disclosed revenue growth or decline in the most recent period. The operating cash flow of 215,187,890 CNY and free cash flow of 314,382,960 CNY suggest the company is generating positive cash, but the net loss indicates that this is not translating into profitability. The capital expenditure of -21,409,910 CNY is relatively small compared to the company's total assets, suggesting limited investment in growth. The company faces a medium liquidity risk, with a debt-to-equity ratio of 0.09 and a current ratio of 2.44. The risk assessment indicates that the company has negative net cash after subtracting total debt, which could limit its ability to fund operations or invest in growth without external financing. The dilution risk is low, with no significant changes in shares outstanding between basic and diluted shares. No recent events, such as filings or transcripts, are disclosed in the available data. The absence of recent disclosures limits the ability to assess the company's strategic direction or operational changes.
Key takeaways
  • The company is generating positive free cash flow but is reporting a net loss, indicating inefficiencies in cost management or pricing.
  • The company's return on equity and return on assets are negative, suggesting poor capital efficiency and operational performance.
  • The company's revenue is not diversified by segment or geography, increasing exposure to regional or product-specific risks.
  • The company's liquidity position is medium risk, with a current ratio of 2.44 and a debt-to-equity ratio of 0.09.
  • The company has a low dilution risk, with no change in shares outstanding between basic and diluted shares.
  • The company's growth trajectory is unclear, with no disclosed revenue growth or decline in the most recent period.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.77B
Gross profit$166.9M
Operating income-$26.8M
Net income-$19.3M
R&D
SG&A
D&A
SBC
Operating cash flow$215.2M
CapEx-$21.4M
Free cash flow$314.4M
Total assets$5.88B
Total liabilities$956.0M
Total equity$4.93B
Cash & equivalents
Long-term debt$432.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.93B
Net cash-$432.3M
Current ratio2.4
Debt/Equity0.1
ROA-0.3%
ROE-0.4%
Cash conversion-11.1%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300821Activity
Op margin-0.7%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-0.5%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin4.4%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity9.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 05:04 UTCJob: ff2dc602